Printer Friendly

MRI diagnosis of Alexander disease.

A 10-month-old term boy, firstborn of a non-consanguinous relationship, presented with a history of prolonged crying and seizures. No significant antenatal history was given, and the child had attained normal milestones until the age of 5 months, after which his development deteriorated. On examination, the head size was 55 cm (more than the 97th percentile for age of the patient). There were no signs or symptoms of raised intracranial tension such as vomiting, papilloedema etc. There was no normal eye contact, and global spasticity was noted.

Multiplanar imaging was done using Ti FLAIR, T2 FLAIR, and T2W FSE sequences, and post-contrast sequences on a 1.5T high-definition magnetic resonance (HDMR) imaging system (GE Signa Excite 1.5T HD, USA). The MR study revealed bilaterally symmetrical confluent white matter hyperintensities on T2W images with frontal preponderance and involvement of the bilateral temporal and parietal lobes (Fig. 1). The subcortical U fibres were involved. Symmetrical bilateral hyperintensities on T2W images were also seen in external capsule, internal capsule, fornix, extreme capsule, corpus callosum and head of caudate nucleus. White matter expansion with resultant widened gyri was noted in the affected regions. All these regions were hypo-intense on T1W and T2 FLAIR. A periventricular rim, T2 hyper, T1 hypointense, was seen along the lateral ventricles (Figs 2a and 2b). The frontal lobes showed symmetrical areas of cavitation in the periventricular region (Fig 3). Patchy symmetrical enhancement was noted in the periventricular rim and deep white matter of the frontal lobes (Figs 4a and 4b). MR spectroscopy did not reveal raised N-acetylaspartate (NAA) or myoinositol peak. Based on these MR findings, a diagnosis of Alexander disease was made.

[FIGURE 1 OMITTED]

[FIGURE 2 OMITTED]

Discussion

Alexander disease (fibrinoid leucodystrophy), originally described by Alexander in 1949, (1) is a rare, fatal, nonfamilial leucoencephalopathy caused by astrocyte dysfunction characterised by missense mutation in the genes coding for glial fibrillary acidic protein(GFAP). (2) The disease is classified into 3 types:

* cerebral Alexanders (type 1), which primarily has an infantile onset with the presence of seizures, psychomotor developmental retardation, macrocephaly and abnormalities in the superior frontal cerebral white matter observed in a brain MRI

* bulbospinal Alexanders (type 2), which primarily has an adult onset with the presence of muscle weakness, hyperreflexia, bulbar or pseudobulbar symptoms, signal abnormalities and atrophy observed in an MRI of the medulla oblongata and upper cervical spinal cord

* intermediate form (type 3) which has the characteristics of both the preceding. (3)

The MR imaging patterns of Alexander disease have been described to be quite specific, dissimilar from patients observed in other white matter abnormalities either of known (4) or unknown origin. Five criteria were described by van der Knaap et al; (4) our patient met 4 of them, with the additional finding of rarely described periventricular cavitation/cysts. (6) Various differential diagnoses that were considered included Canavan disease, which is characterised by a combination of macroencephaly, extensive cerebral white matter changes (without frontal preponderance) and basal ganglia abnormalities. (5) However, contrast enhancement does not occur in Canavan disease, and the typical raised N-acetyl aspartate (NAA) peak on MR spectroscopy was absent in our patient.

[FIGURE 3 OMITTED]

[FIGURE 4 OMITTED]

Traditionally, biopsy was necessary to diagnose the disease, but diagnosis can now be made by MR imaging, using the criteria defined by van der Knaap et ail' Additional confirmation can be obtained via genetic testing of a blood sample for missense mutation in the gene encoding for GFAP.

(1.) Alexander WS. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic child. Brain1949;72:373-381.

(2.) Quinlan RA, Brenner M, Goldman JE, Messing A. GFAP and its role in Alexander disease. Exp Cell Res 2007;313:2077-2087.

(3.) Yoshida T, Nakagawa M. Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation. Neuropathology 2011; Nov 28:14401789. [Epub ahead of print]

(4.) van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: Diagnosis with MR imaging. Am J Neuroradiol 2001;22:541-552.

(5.) Ball WS, Egelhoff JC, Jones BV, et al. Metabolic, Congenital, Neurodegenerative and Toxic Disorders. In:Clinical Magnetic Resonance Imaging, 3rd ed. Edelman RR, Hesselink JR, eds. Philadelphia, USA: Saunders, 2006:1656-1704.

(6.) Klein EA, Anzil AP. Prominent white matter cavitation in an infant with Alexander's disease. Clin Neuropathol 1994;13:31-38.

C G Muralidharan, MB BS, MD, Dip NB (Radiodiagnosis) R P S Tomar, MB BS, MD (Paediatrics)

M H Jalandhar Hospital, Jalandhar, Punjab, India

R Aggarwal, MB BS, MD (Radiodiagnosis)

A F Hospital, Halwara, Punjab

Corresponding author: C Muralidharan (murali.cg@rediffmail.com)

DOI:10.7196/SAJR.656
COPYRIGHT 2012 South African Medical Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:PICTORIAL INTERLUDE; magnetic resonance imaging
Author:Muralidharan, C.G.; Tomar, R.P.S.; Aggarwal, R.
Publication:South African Journal of Radiology
Article Type:Case study
Geographic Code:6SOUT
Date:Sep 1, 2012
Words:772
Previous Article:The sandwich sign.
Next Article:Chest imaging by high-resolution computed tomography (HRCT): diagnosis.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters